Targeted Medical Pharma, Inc. Suite 301 Los Angeles, California 9077

Exhibit 10.2

Targeted Medical Pharma, Inc.

0000 Xxxxxxx Xxxx Xxxxxx

Xxxxx 000

Xxx Xxxxxxx, Xxxxxxxxxx 9077

July 25, 2012

AFH Holding and Advisory, LLC

0000 Xxxxxxxx Xxxxxxxxx

Xxxxx 000

Xxxxxxx Xxxxx, Xxxxxxxxxx 00000

Gentlemen:

Reference is hereby made to the letter agreement (the “Letter Agreement”), dated as of the date hereof, by and between Targeted Medical Pharma, Inc. (the “Company”) and AFH Holding and Advisory, LLC (“AFH Advisory”). The parties desire to clarify the Letter Agreement and clarify their understanding of certain provisions of the Letter Agreement as follows:

1. The parties acknowledge that their understanding of Paragraph 5 (“Board Oversight”) is as follows:

For a period of two (2) years from the date of the Letter Agreement, AFH has the right to disapprove of two nominees for director chosen by the board of directors of the Company.

2. The parties acknowledge that their understanding of Paragraph 6 (“Advisory Role”) is as follows:

With respect to any specific financing or merger/acquisition the Company engages in during this two-year period, the Company may choose not to retain AFH as an advisor.

Please acknowledge your acceptance of your agreement to the foregoing by signing and returning to the undersigned as soon as possible a counterpart of this letter agreement.

		Very truly yours,
		TARGETED MEDICAL PHARMA, INC.
		By:	/s/ Xxxxxxx X. Xxxxx
			Name: Xxxxxxx X. Xxxxx, MD Title: Chief Executive Officer
ACCEPTED AND AGREED TO AS OF JULY 25, 2012:
AFH Holding and Advisory, LLC
By:	/s/ Xxxx X. Xxxxxxxxxxx
	Name: Xxxx X. Xxxxxxxxxxx
	Title: Managing Director